A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Adagrasib D5 | CAS 2641914-61-4 - Request Quote

Picture of Adagrasib D5

Adagrasib D5

SZ CAT No:SZ-A158D01
CAS No
2641914-61-4
Mol.F.
C32H30D5ClFN7O2
Mol.Wt.
609.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Adagrasib D5 is chemically 2-((S)-4-(7-(8-Chloronaphthalen-1-yl)-2-(((S)-1-(methyl-d3)pyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl-8,8-d2)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile. Adagrasib D5 is supplied with detailed characterization data compliant with regulatory guideline. Adagrasib D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Adagrasib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2641914-61-4

Purchase 2641914-61-4

Order 2641914-61-4

Enquire 2641914-61-4

price of 2641914-61-4

2641914-61-4 Supplier

2641914-61-4 Manufacturer

2641914-61-4 Exporter

buy high quality Adagrasib D5

Purchase Adagrasib D5

Adagrasib D5 suppliers

Adagrasib D5 manufacturers

Adagrasib D5 price

Order Adagrasib D5

Enquire Adagrasib D5

Adagrasib D5 cost

Adagrasib D5 Supplier

Adagrasib D5 Distributor

Adagrasib D5 for Method Validation

Adagrasib Reference Standard

Adagrasib D5 for ANDA Filing

Adagrasib D5 for Forced Degradation Studies

Adagrasib D5 Identification Standards

Adagrasib D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,